Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Convertible Notes, Sold Out, 2021 Q2

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Sold out

In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.

  • Q2 2021: Stock SEA LTD; Country of operation —; Class NOTE 1.000%12/0; Principal before $142,131,000.
  • Q2 2021: Stock INSULET CORP; Country of operation —; Class NOTE 1.375%11/1; Principal before $174,883,000.
  • Q2 2021: Stock TELADOC HEALTH INC; Country of operation —; Class NOTE 1.375% 5/1; Principal before $137,648,000.
  • Q2 2021: Stock SQUARE INC; Country of operation —; Class NOTE 0.500% 5/1; Principal before $80,260,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q2 2021SEA LTD
CUSIP 81141RAD2
—NOTE 1.000%12/0$142,131,000$0-142,131,000$632,517$0-$632,5172021-08-16
Q2 2021INSULET CORP
CUSIP 45784PAH4
—NOTE 1.375%11/1$174,883,000$0-174,883,000$489,877$0-$489,8772021-08-16
Q2 2021TELADOC HEALTH INC
CUSIP 87918AAC9
—NOTE 1.375% 5/1$137,648,000$0-137,648,000$467,030$0-$467,0302021-08-16
Q2 2021SQUARE INC
CUSIP 852234AD5
—NOTE 0.500% 5/1$80,260,000$0-80,260,000$234,649$0-$234,6492021-08-16
Q2 2021NUANCE COMMUNICATIONS INC
CUSIP 67020YAN0
—NOTE 1.250% 4/0$61,147,000$0-61,147,000$139,333$0-$139,3332021-08-16
Q2 2021PROOFPOINT INC
CUSIP 743424AF0
—NOTE 0.250% 8/1$73,650,000$0-73,650,000$78,635$0-$78,6352021-08-16
Q2 2021LIBERTY MEDIA CORP DEL
CUSIP 531229AF9
—NOTE 1.000% 1/3$58,319,000$0-58,319,000$74,561$0-$74,5612021-08-16
Q2 2021NUANCE COMMUNICATIONS INC
CUSIP 67020YAK6
—DBCV 1.000%12/1$36,500,000$0-36,500,000$67,620$0-$67,6202021-08-16
Q2 2021SNAP INC
CUSIP 83304AAB2
—NOTE 0.750% 8/0$25,500,000$0-25,500,000$60,166$0-$60,1662021-08-16
Q2 2021COWEN INC
CUSIP 223622AE1
—NOTE 3.000%12/1$24,181,000$0-24,181,000$49,816$0-$49,8162021-08-16
Q2 2021NEVRO CORP
CUSIP 64157FAA1
—NOTE 1.750% 6/0$29,066,000$0-29,066,000$42,190$0-$42,1902021-08-16
Q2 2021IONIS PHARMACEUTICALS INC
CUSIP 462222AB6
—NOTE 0.125%12/1$42,905,000$0-42,905,000$41,032$0-$41,0322021-08-16
Q2 2021LUMENTUM HLDGS INC
CUSIP 55024UAB5
—NOTE 0.250% 3/1$18,000,000$0-18,000,000$28,904$0-$28,9042021-08-16
Q2 2021REALPAGE INC
CUSIP 75606NAC3
—NOTE 1.500% 5/1$21,300,000$0-21,300,000$27,330$0-$27,3302021-08-16
Q2 2021INPHI CORP
CUSIP 45772FAC1
—NOTE 0.750% 9/0$7,588,000$0-7,588,000$23,979$0-$23,9792021-08-16
Q2 2021WAYFAIR INC
CUSIP 94419LAF8
—NOTE 1.000% 8/1$10,500,000$0-10,500,000$23,275$0-$23,2752021-08-16
Q2 2021INTERDIGITAL INC
CUSIP 45867GAB7
—NOTE 2.000% 6/0$20,720,000$0-20,720,000$22,025$0-$22,0252021-08-16
Q2 2021AMERICAN AIRLS GROUP INC
CUSIP 02376RAF9
—NOTE 6.500% 7/0$12,607,000$0-12,607,000$21,656$0-$21,6562021-08-16
Q2 2021OMEROS CORP
CUSIP 682143AG7
—NOTE 5.250% 2/1$17,000,000$0-17,000,000$21,170$0-$21,1702021-08-16
Q2 2021THERAVANCE INC
CUSIP 88338TAB0
—NOTE 2.125% 1/1$20,389,000$0-20,389,000$20,513$0-$20,5132021-08-16
Q2 2021INSMED INC
CUSIP 457669AA7
—NOTE 1.750% 1/1$17,686,000$0-17,686,000$19,753$0-$19,7532021-08-16
Q2 2021GREENBRIER COS INC
CUSIP 393657AK7
—NOTE 2.875% 2/0$17,520,000$0-17,520,000$19,181$0-$19,1812021-08-16
Q2 2021SAILPOINT TECHNOLOGIES HLDGS
CUSIP 78781PAB1
—NOTE 0.125% 9/1$8,840,000$0-8,840,000$16,468$0-$16,4682021-08-16
Q2 2021RETROPHIN INC
CUSIP 761299AB2
—NOTE 2.500% 9/1$16,000,000$0-16,000,000$16,415$0-$16,4152021-08-16
Q2 2021NUVASIVE INC
CUSIP 670704AJ4
—NOTE 0.375% 3/1$14,500,000$0-14,500,000$14,820$0-$14,8202021-08-16
Q2 2021ZYNGA INC
CUSIP 98986TAB4
—NOTE 0.250% 6/0$10,451,000$0-10,451,000$14,281$0-$14,2812021-08-16
Q2 2021SEACOR HOLDINGS INC
CUSIP 811904AN1
—NOTE 3.250% 5/1$14,642,000$0-14,642,000$14,065$0-$14,0652021-08-16
Q2 2021SHIP FINANCE INTERNATIONAL L
CUSIP G81075AF3
—NOTE 5.750%10/1$12,693,000$0-12,693,000$12,739$0-$12,7392021-08-16
Q2 2021WAYFAIR INC
CUSIP 94419LAD3
—NOTE 1.125%11/0$4,625,000$0-4,625,000$12,685$0-$12,6852021-08-16
Q2 2021ON SEMICONDUCTOR CORP
CUSIP 682189AP0
—NOTE 1.625%10/1$5,600,000$0-5,600,000$11,612$0-$11,6122021-08-16
Q2 2021RAMBUS INC DEL
CUSIP 750917AG1
—NOTE 1.375% 2/0$9,701,000$0-9,701,000$11,604$0-$11,6042021-08-16
Q2 2021VISHAY INTERTECHNOLOGY INC
CUSIP 928298AP3
—NOTE 2.250% 6/1$9,250,000$0-9,250,000$10,101$0-$10,1012021-08-16
Q2 2021CSG SYS INTL INC
CUSIP 126349AF6
—NOTE 4.250% 3/1$8,966,000$0-8,966,000$9,449$0-$9,4492021-08-16
Q2 2021AERIE PHARMACEUTICALS INC
CUSIP 00771VAB4
—NOTE 1.500%10/0$8,986,000$0-8,986,000$9,343$0-$9,3432021-08-16
Q2 2021IQIYI INC
CUSIP 46267XAD0
—NOTE 2.000% 4/0$10,000,000$0-10,000,000$9,304$0-$9,3042021-08-16
Q2 20218X8 INC NEW
CUSIP 282914AB6
—NOTE 0.500% 2/0$5,015,000$0-5,015,000$6,991$0-$6,9912021-08-16
Q2 2021REPLIGEN CORP
CUSIP 759916AB5
—NOTE 0.375% 7/1$2,500,000$0-2,500,000$4,413$0-$4,4132021-08-16
Q2 2021PRETIUM RES INC
CUSIP 74139CAB8
—NOTE 2.250% 3/1$3,150,000$0-3,150,000$3,228$0-$3,2282021-08-16
Q2 2021SSR MNG INC
CUSIP 784730AB9
—NOTE 2.500% 4/0$2,000,000$0-2,000,000$2,282$0-$2,2822021-08-16
Q2 2021LIGAND PHARMACEUTICALS INC
CUSIP 53220KAF5
—NOTE 0.750% 5/1$1,000,000$0-1,000,000$1,034$0-$1,0342021-08-16
Q2 2021SPLUNK INC
CUSIP 848637AD6
—NOTE 1.125% 9/1$500,000$0-500,000$592$0-$5922021-08-16